Related Experiment Video
Updated: Jul 15, 2026
07:32
Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining
Published on: May 23, 2025
[Iron overload and chronic liver diseases].
Armand Abergel1, Marc Ruivard, Corinne Bonny
1Centre d'hépato-gastroentérologie, Hôtel-Dieu, 63058 Clermont-Ferrand Cedex 1. aabergel@chu-clermontferrand.fr
La Revue Du Praticien
|April 10, 2007
Summary
Liver iron overload is linked to several liver diseases, often causing hyperferritinemia. Genetic testing for C282Y mutation is recommended for specific patients with elevated iron levels.
Area of Science:
- Hepatology
- Internal Medicine
- Genetics
Background:
- Liver diseases like alcohol liver disease and NAFLD can present with abnormal iron tests.
- While abnormal iron tests are common, true iron overload is infrequent in these conditions.
- Hyperferritinemia in liver disease patients can stem from cellular necrosis, increased synthesis, inflammation, or iron overload.
Purpose of the Study:
- To explore the mechanisms behind liver iron overload in chronic liver diseases.
- To investigate the role of iron in hepatic fibrogenesis and carcinogenesis.
- To guide the clinical management of iron overload in patients with chronic liver conditions.
Main Methods:
- Review of existing literature on liver diseases and iron metabolism.
- Analysis of diagnostic criteria for iron overload and C282Y mutation testing.
- Discussion of ongoing research into iron's role in liver disease progression.
Main Results:
- Hyperferritinemia is a common finding but not always indicative of iron overload.
- C282Y mutation testing is advised for patients with specific criteria (e.g., alcohol cessation, high transferrin saturation).
- Iron's role in liver fibrogenesis and cancer development is an active area of research.
Conclusions:
- Differentiating causes of hyperferritinemia is crucial in liver disease patients.
- Targeted genetic testing can identify hereditary hemochromatosis in at-risk individuals.
- Further research will clarify the therapeutic roles of venesection and iron chelators.
Related Concept Videos
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:21Chronic Pancreatitis II: Pathophysiology
Chronic pancreatitis is a progressive and irreversible inflammation of the pancreas, most often caused by long-term alcohol abuse, but it can also be related to ductal obstruction, smoking, or genetic factors.Chronic pancreatitis occurs when the pancreas is repeatedly exposed to harmful agents like alcohol, smoking, ductal obstruction, or genetic predisposition. These factors lead to the release of toxic metabolites and inflammatory cytokines, sustaining chronic inflammation in the pancreatic...